BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $791,100 | -88.8% | 30,000 | -92.7% | 0.22% | -91.0% |
Q2 2023 | $7,071,488 | -39.9% | 411,133 | -42.1% | 2.47% | -36.4% |
Q1 2023 | $11,768,484 | +42.8% | 709,800 | +43.7% | 3.88% | +29.8% |
Q4 2021 | $8,241,000 | -73.1% | 494,046 | -24.5% | 2.99% | -61.4% |
Q3 2021 | $30,673,000 | -8.5% | 654,435 | +19.0% | 7.75% | -35.5% |
Q2 2021 | $33,528,000 | -5.8% | 550,000 | -4.8% | 12.00% | -0.6% |
Q1 2021 | $35,574,000 | +222.8% | 577,500 | +272.6% | 12.08% | +106.8% |
Q4 2020 | $11,022,000 | – | 155,000 | – | 5.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |